BOB Capital Suggests Buying This Pharma Stock Near 52 Week Low For 60% Gains

BOB Capital Markets Ltd is bullish on Aurobindo Pharma Ltd. and has given a buy call for a target price of Rs 850. Recently, the company acquired Veritaz Healthcare for Rs 1.7bn to enter the domestic formulation business. Stock Overview -

from Tax Saving Investments | Tax Saving Tips & News | Income Tax India – Oneindia Money https://ift.tt/JXMeg2b
via IFTTT